Thermo Fisher Scientific Inc. (TMO)
Company Info
Highlights
$153.28B
$17.03
23.84
1.65
$42.90B
$17.83B
$10.60B
$390.50 - $626.49
$570.17
1.20%
1.51
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
Thermo Fisher Scientific Inc. (TMO) returned -22.10% year-to-date (YTD) and -32.20% over the past 12 months. Over the past 10 years, TMO delivered an annualized return of 12.40%, outperforming the S&P 500 benchmark at 10.79%.
TMO
-22.10%
-8.18%
-23.91%
-32.20%
3.64%
12.40%
^GSPC (Benchmark)
0.60%
9.64%
-0.54%
11.47%
15.67%
10.79%
Monthly Returns
The table below presents the monthly returns of TMO, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 14.90% | -11.51% | -5.85% | -13.79% | -5.61% | -22.10% | |||||||
| 2024 | 1.54% | 5.79% | 2.00% | -2.15% | -0.13% | -2.57% | 10.91% | 0.28% | 0.63% | -11.68% | -3.05% | -1.70% | -1.72% |
| 2023 | 3.57% | -5.01% | 6.46% | -3.73% | -8.37% | 2.68% | 5.16% | 1.54% | -9.08% | -12.13% | 11.46% | 7.14% | -3.36% |
| 2022 | -12.88% | -6.42% | 8.64% | -6.39% | 2.65% | -4.22% | 10.15% | -8.87% | -6.94% | 1.34% | 9.00% | -1.65% | -17.29% |
| 2021 | 9.43% | -11.70% | 1.46% | 3.03% | -0.16% | 7.51% | 7.05% | 2.77% | 3.00% | 10.81% | -0.04% | 5.48% | 43.54% |
| 2020 | -3.60% | -7.15% | -2.40% | 18.01% | 4.34% | 3.83% | 14.24% | 3.63% | 2.98% | 7.16% | -1.72% | 0.22% | 43.72% |
| 2019 | 9.78% | 5.66% | 5.53% | 1.36% | -3.77% | 10.07% | -5.45% | 3.38% | 1.53% | 3.68% | 3.96% | 3.54% | 45.55% |
| 2018 | 18.03% | -6.93% | -0.94% | 1.88% | -0.99% | -0.46% | 13.22% | 1.95% | 2.15% | -4.27% | 6.81% | -10.26% | 18.21% |
| 2017 | 8.00% | 3.47% | -2.50% | 7.64% | 4.51% | 1.06% | 0.61% | 6.61% | 1.18% | 2.45% | -0.55% | -1.42% | 35.03% |
| 2016 | -6.90% | -2.17% | 9.72% | 1.88% | 5.21% | -2.55% | 7.50% | -4.19% | 4.62% | -7.56% | -4.71% | 0.81% | -0.12% |
| 2015 | -0.06% | 3.83% | 3.46% | -6.45% | 3.14% | 0.22% | 7.53% | -10.15% | -2.34% | 6.95% | 5.83% | 2.61% | 13.75% |
| 2014 | 3.40% | 8.16% | -3.34% | -5.19% | 2.55% | 1.06% | 2.97% | -1.06% | 1.36% | -3.39% | 9.97% | -2.98% | 13.06% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of TMO is 3, meaning it’s performing worse than 97% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Thermo Fisher Scientific Inc. (TMO) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Thermo Fisher Scientific Inc. provided a 0.40% dividend yield over the last twelve months, with an annual payout of $1.60 per share. The company has been increasing its dividends for 12 consecutive years.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $1.60 | $1.56 | $1.40 | $1.20 | $1.04 | $0.88 | $0.76 | $0.68 | $0.60 | $0.60 | $0.60 | $0.60 |
Dividend yield | 0.40% | 0.30% | 0.26% | 0.22% | 0.16% | 0.19% | 0.23% | 0.30% | 0.32% | 0.43% | 0.42% | 0.48% |
Monthly Dividends
The table displays the monthly dividend distributions for Thermo Fisher Scientific Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | $0.00 | $0.43 | $0.00 | $0.00 | $0.43 | |||||||
| 2024 | $0.00 | $0.00 | $0.39 | $0.00 | $0.00 | $0.39 | $0.00 | $0.00 | $0.39 | $0.00 | $0.00 | $0.39 | $1.56 |
| 2023 | $0.00 | $0.00 | $0.35 | $0.00 | $0.00 | $0.35 | $0.00 | $0.00 | $0.35 | $0.00 | $0.00 | $0.35 | $1.40 |
| 2022 | $0.00 | $0.00 | $0.30 | $0.00 | $0.00 | $0.30 | $0.00 | $0.00 | $0.30 | $0.00 | $0.00 | $0.30 | $1.20 |
| 2021 | $0.00 | $0.00 | $0.26 | $0.00 | $0.00 | $0.26 | $0.00 | $0.00 | $0.26 | $0.00 | $0.00 | $0.26 | $1.04 |
| 2020 | $0.00 | $0.00 | $0.22 | $0.00 | $0.00 | $0.22 | $0.00 | $0.00 | $0.22 | $0.00 | $0.00 | $0.22 | $0.88 |
| 2019 | $0.00 | $0.00 | $0.19 | $0.00 | $0.00 | $0.19 | $0.00 | $0.00 | $0.19 | $0.00 | $0.00 | $0.19 | $0.76 |
| 2018 | $0.00 | $0.00 | $0.17 | $0.00 | $0.00 | $0.17 | $0.00 | $0.00 | $0.17 | $0.00 | $0.00 | $0.17 | $0.68 |
| 2017 | $0.00 | $0.00 | $0.15 | $0.00 | $0.00 | $0.15 | $0.00 | $0.00 | $0.15 | $0.00 | $0.00 | $0.15 | $0.60 |
| 2016 | $0.00 | $0.00 | $0.15 | $0.00 | $0.00 | $0.15 | $0.00 | $0.00 | $0.15 | $0.00 | $0.00 | $0.15 | $0.60 |
| 2015 | $0.00 | $0.00 | $0.15 | $0.00 | $0.00 | $0.15 | $0.00 | $0.00 | $0.15 | $0.00 | $0.00 | $0.15 | $0.60 |
| 2014 | $0.15 | $0.00 | $0.00 | $0.15 | $0.00 | $0.00 | $0.15 | $0.00 | $0.00 | $0.15 | $0.60 |
Dividend Yield & Payout
Dividend Yield
Thermo Fisher Scientific Inc. has a dividend yield of 0.40%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.
Payout Ratio
Thermo Fisher Scientific Inc. has a payout ratio of 7.31%, which is below the market average. This means Thermo Fisher Scientific Inc. returns a smaller proportion of its earnings to shareholders as dividends, suggesting it retains a higher portion for reinvestment, growth, or debt payment.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the Thermo Fisher Scientific Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Thermo Fisher Scientific Inc. was 71.16%, occurring on Apr 15, 1999. Recovery took 1698 trading sessions.
The current Thermo Fisher Scientific Inc. drawdown is 38.80%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -71.16% | Jan 2, 1998 | 323 | Apr 15, 1999 | 1698 | Jan 13, 2006 | 2021 |
| -60.35% | Mar 6, 1987 | 165 | Oct 28, 1987 | 406 | Jun 7, 1989 | 571 |
| -53.91% | Aug 18, 2008 | 68 | Nov 20, 2008 | 626 | May 18, 2011 | 694 |
| -42.05% | Oct 4, 1989 | 259 | Oct 11, 1990 | 144 | May 8, 1991 | 403 |
| -39.07% | Jan 3, 2022 | 841 | May 9, 2025 | — | — | — |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Thermo Fisher Scientific Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Thermo Fisher Scientific Inc., comparing actual results with analytics estimates. The company met analyst expectations for EPS in the past quarter.
Valuation
The Valuation section provides an overview of how Thermo Fisher Scientific Inc. is priced in the market compared to other companies in the Diagnostics & Research industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for TMO, comparing it with other companies in the Diagnostics & Research industry. Currently, TMO has a P/E ratio of 23.8. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for TMO compared to other companies in the Diagnostics & Research industry. TMO currently has a PEG ratio of 1.6. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for TMO relative to other companies in the Diagnostics & Research industry. Currently, TMO has a P/S ratio of 3.6. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for TMO in comparison with other companies in the Diagnostics & Research industry. Currently, TMO has a P/B value of 3.3. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |